HEALTH CARE & MEDICINE
ASIAHEALTH CARE & MEDICINE
Boral slashes more local jobs: report
Total cuts across global operations hit 1100 as group rationalises businesses. Read More | View Original Article
Newman says he will back 'bold and important' NDIS. Read More | View Original Article
Cab-catching app Uber seeks funding for $1bn valuation
Start-up aims to join the likes of SurveyMonkey and Pinterest in achieving a 10-figure valuation. Read More | View Original Article
Chinese manufacturing slows in April
National Bureau of Statistics data shows 7th month of expansion in activity, however pace of growth in sector weakens more than expected. Read More | View Original Article
أي بي أم ووزارة الصحة السعودية تطلقان نظام جديد للتصدي للأمراض المعدية
أعلنت شركة أي بي أم، المدرجة في بورصة نيويورك تحت الرمز: NYSE: IBM، ووزارة الصحة السعودية عن نجاح تطبيق نظام الصحة العامة المقدم من "أي بي أم" لإدارة الأمراض في جدة ومكة والطائف والقنفذة، حيث يساعد النظام على إدارة مخاطر الأمراض المعدية في جميع أنحاء المملكة العربية السعودية. وسيوفر النظام الجديد القائم على السحابة للمتخصصين في الصحة العامة الأدوات اللازمة لتوفير حماية أفضل لصحة المواطنين في المملكة مع تطبيق آمن وسهل الاستخدام لجمع وتبادل وتحليل المعلومات الصحية الضرورية لإدارة تفشي الأمراض العامة مثل الالتهاب الرئوي اللانمطي الحاد، والأنفلونزا وغيرها من الأمراض المعدية. Read More | View Original Article
إبرام اتفاقية لتوسعة مستشفى تخصصي جدة بتكلفة 1.7 مليار ريال
أعلن مدير العلاقات العامة والإعلام بمستشفى الملك فيصل التخصصي بجدة نجيب يماني، عن إبرام اتفاقية مشروع توسعة وتطوير مستشفى الملك فيصل التخصصي ومركز الأبحاث فرع جدة تمت ترسيته بتاريخ 30 ذي القعدة 1433هـ، وسُجل العقد في 18/2/1434هـ، ومدته ثلاث سنوات بقيمة 1.770.420.638 ريالاً، وسُلم الموقع بعد صدور التوجيه السامي رقم 16774 وتاريخ 4/5/1434هـ، والقاضي بتسليم الموقع لإدارة المستشفى بجدة على مساحة أرض تبلغ مليوني متر مربع، ومساحة مبانٍ تبلغ 370 ألف متر مربع، مبيناً أنه تم إعداد المخطط العام ليشمل التوسعة على مراحل، حيث يصل عدد الأسرّة إلى ألفي سرير مع عمل مشروع لإسكان منسوبي المستشفى في الموقع نفسه، Read More | View Original Article
Danish Lundbeck posts USD365.25m Q1 operating profit
(MENAFN) Denmark's Lundbeck announced that its operating profit grew to USD265.25 million from USD155.06 million in 2012's same period, reported Reuters. The drug manufacturer's ... Read More | View Original Article
UAE makes organ transplant breakthrough
(MENAFN - Khaleej Times) The country's first cadaveric organ transplant was performed on a 23-year old Somali woman with kidney failure. The landmark surgery was carried out a few days ago at the ... Read More | View Original Article
UAE health ministry authorises DHA to oversee pharmacies
The Dubai Health Authority (DHA) has been authorised by the health ministry to carry out some functions of the pharmaceutical profession in the emirate, Gulf Today has reported. The regulator is now responsible for the licensing and renewal of pharmacies, licensing and renewal of pharmacists and surveillance of pharmacies and pharmacists in Dubai to ensure their abidance with the federal rules and regulations, a ministry circular said. Read More | View Original Article
This new 194-page report from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market. Read More | View Original Article
The research service on Advances in MRI Systems Market (2013-2018) – Technology Trend Analysis – By Architecture, Field Strengths, Technology and Applications in Medical Diagnostics with Market Landscape Analysis – Estimates up to 2018, is an attempt to showcase the technology and market impact of existing and emerging MR systems having a huge growth potential in medical imaging for the coming five years. Magnetic resonance imaging (MRI) is a medical imaging technique that makes use of magnetism, radio waves, and a computer to produce images of body structures. Read More | View Original Article
U.S. Dental Bone Graft Substitutes and Other Biomaterials Market
Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012. In 2012, the total U.S. market for dental bone graft substitutes and other biomaterials was valued at over $222 million. This value includes bone graft substitutes, dental growth factor products and dental membranes; however, it excludes autografts, which have no intrinsic value but had a market potential of $33.6 million. Read More | View Original Article
Brazilian Large Bone & Joint Orthopedic Devices Market
The Brazilian orthopedic large joint reconstruction device market is expected to reach $502.4 million by 2019.The orthopedic large joint reconstruction device market includes hip reconstruction devices, knee reconstruction devices and bone cements used to help adhere the implants to bone. Large joint arthroplasty experienced a continued increase in demand in 2012, attributed to the aging Brazilian population and an increased number of patients able to afford these procedures. Read More | View Original Article
Cancer Monoclonal Antibody Partnering Terms and Agreements
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Read More | View Original Article
Autoimmune Drugs Markets in China
China''s demand for autoimmune drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
European Market for Interventional Cardiology Devices
Despite turbulent macroeconomic conditions in recent years, the European market for interventional cardiology devices is expected to remain stable over the forecast period. Advancements in specific technologies and practices such as drug management, drug-eluting stents, specialty guidewires, micro-introducer sheaths, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices. Read More | View Original Article
Cancer Vaccine Partnering Terms and Agreements
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Read More | View Original Article
Blood Disease Treatment Drugs Markets in China
China''s demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
Hypertension Treatment Drugs Markets in China
China''s demand for hypertension treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
Brazilian Interventional Cardiology Devices Market
In 2012, the interventional cardiology devices market was valued at almost $514 million, an increase of 3.8% over the previous year. Increased procedural volume and a growing private healthcare sector will serve to drive growth in this market over the forecast period. The number of both angiography and angioplasty procedures performed in Brazil will continue to increase as more of the population is brought into a culture of available healthcare. Historically, Brazil has had far fewer procedures per million people than countries in Europe or in the United States. Read More | View Original Article
Antibody Partnering Terms and Agreements
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. Read More | View Original Article
European Market for Interventional Cardiology Devices
Despite turbulent macroeconomic conditions in recent years, the European market for interventional cardiology devices is expected to remain stable over the forecast period.Advancements in specific technologies and practices such as drug management, drug-eluting stents, specialty guidewires, micro-introducer sheaths, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices. Read More | View Original Article
Mental Illness Treatment Drugs Markets in China
China''s demand for mental illness treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
Brazilian Large Bone & Joint Orthopedic Devices Market
The Brazilian orthopedic large joint reconstruction device market is expected to reach $502.4 million by 2019. The orthopedic large joint reconstruction device market includes hip reconstruction devices, knee reconstruction devices and bone cements used to help adhere the implants to bone. Large joint arthroplasty experienced a continued increase in demand in 2012, attributed to the aging Brazilian population and an increased number of patients able to afford these procedures. Read More | View Original Article
Latin American Dental Prosthetics and CAD/CAM Devices Market
In 2012, the total Latin American dental prosthetics market increased by 10.9% over 2011. Highgrowth is expected to continue over the forecast period.The Latin American market includes Mexico, Brazil and Argentina. Over the past few years the popularity of implants has driven demand for prosthetics over implant restorations. In addition to the popularity of implants, the population in both Argentina and Brazil is aging, and more patients are in need of dental treatment. Read More | View Original Article
Anti-Obesity Drugs Markets in China
China''s demand for anti-obesity drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
Anti-Tumor Drugs Markets in China
China''s demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China''s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.... Read More | View Original Article
GBI Research’s “Ultrasound Systems Market to 2019 – Technological Advancements, Wide Applications and Device Portability to Drive Future Growth” report examines the market, competitive landscape, and trends for the following two ultrasound systems market segments: color doppler ultrasound systems and B/W ultrasound systems. The report provides comprehensive information on the key trends affecting these segments, and key analytical content related to market dynamics. Read More | View Original Article
Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery, preclinical and clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.The report provides a detailed understanding and analysis of how and why companies enter discovery, preclinical and clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. Read More | View Original Article
U.S. Dental Bone Graft Substitutes and Other Biomaterials Market
Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012.In 2012, the total U.S. market for dental bone graft substitutes and other biomaterials was valued at over $222 million. This value includes bone graft substitutes, dental growth factor products and dental membranes; however, it excludes autografts, which have no intrinsic value but had a market potential of $33.6 million. Read More | View Original Article
